bmiMD vs Calibrate: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

bmiMD beats Calibrate overall, scoring 8/10 vs 7.7/10. Calibrate is more affordable at $199/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Calibrate for users who want a physician-led metabolic health program with.

A side-by-side comparison of bmiMD and Calibrate covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

bmiMD

#9 of 48
8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

Calibrate

#21 of 48
7.7/10

Metabolic health company offering a physician-led GLP-1 program restructured in 2026: $199/mo with a 3-month minimum commitment (no more $1,649 one-time enrollment fee). Includes nutrition coaching, labs, a smart scale, and a 10%+ weight-loss guarantee with 50% money-back.

Visit Calibrate
FeaturebmiMDCalibrate
Our Score8/107.7/10
Starting Price$319/mo$199/mo
Medication TypeBothBoth
Insurance AcceptedNoYes
Best ForBudget-first users who want affordable GLP-1 accessUsers who want a physician-led metabolic health program with a 3-month commitment and a weight-loss guarantee
Ranking#9#21

Pros & Cons Compared

bmiMD

Pros

  • +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
  • +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
  • +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
  • +HSA/FSA accepted for all programs

Cons

  • Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
  • $29.99 shipping fee per order — most competitors include free shipping
  • $50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind

Calibrate

Pros

  • +2026 pricing rewrite — flat $199/mo with 3-month commitment ($597 upfront), then month-to-month. The old $1,649 one-time enrollment fee was removed.
  • +Board-certified physicians with metabolic health specialization lead treatment
  • +10%+ body-weight-loss guarantee with 50% money-back if not met
  • +Includes labs, nutrition coaching, personalized smart scale, and sleep/exercise support

Cons

  • $597 upfront (3-month commitment) is a meaningful barrier vs. month-to-month competitors
  • Medication cost is separate and varies significantly by payer route
  • Fewer medications in the menu than larger marketplaces like Ro or Found
  • Onboarding still takes 2-3 weeks to complete baseline labs and treatment plan

Our Verdict

bmiMD edges out Calibrate with a score of 8/10 vs 7.7/10. If budget is your priority, Calibrate starts at $199/mo compared to bmiMD's $319/mo. Calibrate accepts insurance, which can significantly reduce your out-of-pocket costs. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Calibrate if you want: users who want a physician-led metabolic health program with a 3-month commitment and a weight-loss guarantee.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither bmiMD nor Calibrate feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try bmiMD

Starting at $319/mo

Visit bmiMD

Try Calibrate

Starting at $199/mo

Visit Calibrate

Related comparisons

Other matchups readers comparing bmiMD or Calibrate tend to look at next.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.